Floré by Sun Genomics

📍 San Diego, United States🗓 Founded 2016👥 23 employees💰 Last funded Sep 2023
Biotechnology Research🌐 sungenomics.com
Website LinkedIn
The microbiome is the new frontier gut health and changes to your microbiome signature is now being understood as a central conduit of health and disease. IBD, IBS, Crohns, colitis, type I diabetes, arthritis, metabolic syndrome, and several autoimmune disorders have all been associated with microbiome changes also known as dysbiosis. When you total the number of individuals affected by these diseases, over 80% Americans suffer from dysbiosis annually. With this much science there still arent real solutions for dysbiosis. And since dysbiosis is the result of changes to the 1000s different microbes of our gut it is nearly impossible to find the right remedy for your specific dysbiosis. Sun Genomics is empowering the consumer to educate themselves about their microbiome signature and make informed, as well as transparent, product selections to manage their dysbiosis. We are helping consumers realize the power of their microbiota through genomics, probiotics, microbiology, informatics, and software.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
New Zealand
1
United States
1
Frequently asked questions
Who invested in Floré by Sun Genomics?
Floré by Sun Genomics has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Floré by Sun Genomics last raise funding?
The most recent investment in Floré by Sun Genomics recorded on gritt.io was in September 2023.
When was Floré by Sun Genomics founded?
Floré by Sun Genomics was founded in 2016.
What industry is Floré by Sun Genomics in?
Floré by Sun Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Floré by Sun Genomics based?
Floré by Sun Genomics is headquartered in San Diego, United States.